6 citations · 6 across the 1 of their papers we have counts for
1 paper
Shijie Yuan, Zhanbo Huang, Jiaxin Liu +1
We consider a dose-optimization design for first-in-human oncology trial that aims to identify a suitable dose for late-phase drug development. The proposed approach, called the Ph…